Plexaa

Executive Summary

Plexaa, operating as BLOOM⁴³, is a UK-based digital health company addressing the critical gap in surgical prehabilitation. Its integrated platform combines a smartphone app for patient education and behavioral support with a wearable medical device that delivers thermal preconditioning to the breast tissue before surgery. This dual approach aims to enhance recovery, reduce complications, and empower patients in their surgical journey. Initially targeting breast surgery—a high-volume procedure with significant complication rates—Plexaa's solution has the potential to improve outcomes and reduce healthcare costs. Founded in 2020, the company is at an early stage but benefits from a clear value proposition amidst growing interest in digital therapeutics and prehabilitation.

Upcoming Catalysts (preview)

• Q3 2026Completion of clinical feasibility study in breast surgery patients70% success
• Q2 2026CE marking for the thermal preconditioning wearable device60% success
• Q4 2026Series A funding round to scale commercial operations50% success